|
DENND4C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.224940E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.138600E-03 |
| Normal-vs-Stage2 |
2.755900E-03 |
| Normal-vs-Stage3 |
2.936500E-03 |
| Normal-vs-Stage4 |
5.316900E-03 |
| Stage1-vs-Stage2 |
3.008400E-01 |
| Stage1-vs-Stage3 |
5.150400E-01 |
| Stage1-vs-Stage4 |
4.624400E-01 |
| Stage2-vs-Stage3 |
6.125800E-01 |
| Stage2-vs-Stage4 |
7.966400E-01 |
| Stage3-vs-Stage4 |
8.261600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.140800E-03 |
| Normal-vs-AfricanAmerican |
3.118000E-01 |
| Normal-vs-Asian |
4.436500E-03 |
| Caucasian-vs-AfricanAmerican |
3.072000E-01 |
| Caucasian-vs-Asian |
4.972600E-01 |
| AfricanAmerican-vs-Asian |
1.882430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.099900E-03 |
| Normal-vs-Female |
2.698900E-03 |
| Male-vs-Female |
5.019000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.430300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.994900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.763700E-03 |
| Normal-vs-Age(81-100Yrs) |
8.981200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.045000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.891600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.198420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.482400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.908190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.565400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.630400E-01 |
| Classical-VS-Follicular |
2.814400E-02 |
| Classical-VS-Other |
5.992200E-01 |
| Classical-VS-Normal |
1.291520E-02 |
| Tall-VS-Follicular |
1.362170E-01 |
| Tall-VS-Other |
5.331200E-01 |
| Tall-VS-Normal |
1.168000E-01 |
| Follicular-VS-Other |
8.381000E-01 |
| Follicular-VS-Normal |
2.761300E-04 |
| Other-VS-Normal |
1.385390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.807800E-04 |
| Normal-vs-N1 |
1.979490E-03 |
| N0-vs-N1 |
6.481400E-01 |
|
|
